Altered secretory leukocyte protease inhibitor expression in the uterine decidua of tubal compared with intrauterine pregnancy

Human Reproduction

Volumn 23, Issue 7, 2008, Pages 1485-1490

  Dalgetty, D M ^a   Sallenave, J M ^b,c   Critchley, H O D ^a   Williams, A R ^d   Tham, W Y ^a   King, A E ^a   Horne, A W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Elafin; Secretory leukocyte protease inhibitor; Tubal pregnancy; Uterine decidua

Indexed keywords

DNA; ELAFIN; MESSENGER RNA; PROGESTERONE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DNA EXTRACTION; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENE MUTATION; GESTATION PERIOD; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LEUKOCYTE COUNT; PREGNANCY TERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SPONTANEOUS ABORTION; SURGICAL TECHNIQUE; TROPHOBLAST; UTERINE TUBE PREGNANCY; UTERUS CAVITY;

EID: 44949230177     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den130     Document Type: Article

References (52)

1. Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol 2008;77:7-13.
2. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walters P. Molecular Biology of the Cell. 4th edn. New York and London: Garland Science, 2002. ISBN 0-8153-3218-1.
3. Angelov N, Moutsopoulos N, Jeong MJ, Nares S, Ashcroft G, Wahl SM. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor. Thromb Haemost 2004;92:288-297.
4. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000;6:1147-1153.
5. Bowie A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000;67:508-514.
6. Bulmer JN, Pace D, Ritson A. Immunoregulatory cells in human decidua: morphology, immunohistochemistry and function. Reprod Nutr Dev 1988;28:1599-1613.
7. Cassell JA, Mercer CH, Sutcliffe L, Petersen I, Islam A, Brook MG, Ross JD, Kinghorn GR, Simms I, Hughes G et al. Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database. BMJ 2006;332:332-334.
8. Christian M, Mak I, White JO, Brosens JJ. Mechanisms of decidualisation. Reprod Biomed Online 2002;4(Suppl 3):24-30.
9. Corker CS, Davidson DW. A radioimmunoassy for testosterone in various biological fluids without chromatography. J Steroid Biochem 1978;9:373-374.
10. Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res 1997;46:382-391.
11. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003;171:6187-6197.
12. Earl U, Lunny AP, Bulmer JN. Leucocyte populations in ectopic tubal pregnancy. J Clin Pathol 1987;40:901-905.
13. Farquhar CM. Ectopic pregnancy. Lancet 2005;366:583-591.
14. Finn CA. The adaptive significance of menstruation. The meaning of menstruation. Hum Reprod 1994;9:1202-1204.
15. Helmig R, Uldbjerg N, Ohlsson K. Secretory leukocyte protease inhibitor in the cervical mucus and in the fetal membranes. Eur J Obstet Gynecol Reprod Biol 1995;59:95-101.
16. Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, Genbecev-Krtolica O, Mavrogianis P, Ferrer K, Kruessel J et al. Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod 2007;76:102-117.
17. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004;5:971-974.
18. Hritz I, Kuester D, Vieth M, Herszenyi L, Stolte M, Roessner A, Tulassay Z, Wex T, Malfertheiner P. Secretory leukocyte protease inhibitor expression in various types of gastritis: a specific role of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2006;18:277-282.
19. Hunt JS. Immunologically relevant cells in the uterus. Biol Reprod. 1994;50:461-466.
20. King A, Loke YW. On the nature and function of human uterine granular lymphocytes. Immunol Today 1991;12:432-435.
21. King AE, Critchley HO, Kelly RW. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Hum Reprod 2000;6:191-196.
22. King AE, Fleming DC, Critchley HO, Kelly RW. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod 2002;8:341-349.
23. King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003a;1:116.
24. King AE, Critchley HO, Sallenave JM, Kelly RW. Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation. J Clin Endocrinol Metab 2003b;88:4426-4431.
25. Kutluay L, Vicdan K, Turan C, Batioglu S, Oguz S, Gokmen O. Tubal histopathology in ectopic pregnancies. Eur J Obstet Gynecol Reprod Biol 1994;57:91-94.
26. Marx L, Arck P, Kapp M, Kieslich C, Dietl J. Leukocyte populations, hormone receptors and apoptosis in eutopic and ectopic first trimester human pregnancies. Hum Reprod 1999;14:1111-1117.
27. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
28. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000;343:338-344.
29. Mitsuhashi H, Asano S, Nonaka T, Hamamura I, Masuda K, Kiyoki M. Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am J Respir Crit Care Med 1996;153:369-374.
30. Mulligan MS, Desrochers PE, Chinnaiyan AM, Gibbs DF, Varani J, Johnson KJ, Weiss SJ. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2. Proc Natl Acad Sci USA 1993;90:11523-11527.
31. Odland JO, Anestad G, Rasmussen S, Lundgren R, Dalaker K. Ectopic pregnancy and chlamydial serology. Int J Gynaecol Obstet 1993;43:271-275.
32. Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PE et al. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest 1996;98:1389-1399.
33. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004;72:5799-5806.
34. Rudolphus A, Stolk J, Dijkman JH, Kramps JA. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am Rev Respir Dis 1993;147:442-447.
35. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 2000;1:87-92.
36. Sallenave JM, Ryle AP. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe Seyler 1991;372:13-21.
37. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994;11:733-741.
38. Schalkwijk J, Wiedow O, Hirose S. The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J 1999;340:569-577.
39. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;7:3.
40. Stewart-Akers AM, Krasnow JS, DeLoia JA. Decidual leukocyte populations in ectopic pregnancies. Fertil Steril 1997;68:1103-1107.
41. Stock RJ. Tubal pregnancy. Associated histopathology. Obstet Gynecol Clin North Am 1991;18:73-94.
42. Sulz L, Valenzuela JP, Salvatierra AM, Ortiz ME, Croxatto HB. The expression of alpha(v) and beta3 integrin subunits in the normal human Fallopian tube epithelium suggests the occurrence of a tubal implantation window. Hum Reprod 1998;13:2916-2920.
43. Taylor CR. An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. Appl Immunohistochem 1994;1:1-11.
44. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986;83:6692-6696.
45. van Bergen BH, Andriessen MP, Spruijt KI, van de Kerkhof PC, Schalkwijk J. Expression of SKALP/elafin during wound healing in human skin. Arch Dermatol Res. 1996;288:458-462.
46. Wex T, Treiber G, Nilius M, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum. Infect Immun 2004a;72:2383-2385.
47. Wex T, Sokic-Milutinovic A, Todorovic V, Bjelovic M, Milosavljevic T, Pesko P, Malfertheiner P. Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases. Dig Dis 2004b;22:390-395.
48. Wex T, Ye S, Treiber G, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa. Helicobacter 2006;11:31-38.
49. Wiedow O, Luademann J, Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun 1991;174:6-10.
50. Wingens M, van Bergen BH, Hiemstra PS, Meis JF, van Vlijmen-Willems IM, Zeeuwen PL, Mulder J, Kramps HA, van Ruissen F, Schalkwijk J. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 1998;111:996-1002.
51. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005;206:306-335.
52. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002;111:867-878.